Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Chemotherapy-induced febrile neutropenia: primary G-CSF prophylaxis indicated during docetaxel cycles.

van Dooijeweert C, van der Wall E, Baas IO.

Neth J Med. 2019 Dec;77(9):310-316.

2.

Self-reported work ability in breast cancer survivors; a prospective cohort study in the Netherlands.

Gregorowitsch ML, van den Bongard HJGD, Couwenberg AM, Young-Afat DA, Haaring C, Van Dalen T, Schoenmaeckers EJP, Agterof MJ, Baas IO, Sier MF, Ernst MF, van Hummel R, Verkooijen HM; UMBRELLA study group.

Breast. 2019 Dec;48:45-53. doi: 10.1016/j.breast.2019.08.004. Epub 2019 Aug 28.

PMID:
31493582
3.

Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells.

Baas I, Delvasto-Nuñez L, Ligthart P, Brouwer C, Folman C, Reis ES, Ricklin D, Lambris JD, Wouters D, de Haas M, Jongerius I, Zeerleder SS.

Haematologica. 2020 Jan 31;105(2):e57-e60. doi: 10.3324/haematol.2019.216028. Print 2020. No abstract available.

4.

Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands.

van Dooijeweert C, Deckers IAG, Baas IO, van der Wall E, van Diest PJ.

Breast Cancer Res Treat. 2019 Jun;175(2):487-497. doi: 10.1007/s10549-019-05180-5. Epub 2019 Mar 1.

5.

The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients.

Gregorowitsch ML, Ghedri A, Young-Afat DA, Bijlsma R, Baas IO, van Schaik-van de Mheen C, Agterof MJ, Göker E, Ten Bokkel Huinink D, van den Bongard HJGD, Verkooijen HM; UMBRELLA study group.

Breast Cancer Res Treat. 2019 Jun;175(2):429-441. doi: 10.1007/s10549-019-05149-4. Epub 2019 Feb 12.

6.

Complement Deposition and IgG Binding on Stored Red Blood Cells Are Independent of Storage Time.

Thielen AJF, Meulenbroek EM, Baas I, Bruggen R, Zeerleder SS, Wouters D.

Transfus Med Hemother. 2018 Nov;45(6):378-384. doi: 10.1159/000486759. Epub 2018 Mar 9.

7.

Acute hemolytic transfusion reaction due to a warm reactive anti-A1.

Helmich F, Baas I, Ligthart P, Bosch M, Jonkers F, de Haas M, van der Graaf F.

Transfusion. 2018 May;58(5):1163-1170. doi: 10.1111/trf.14537. Epub 2018 Feb 26.

PMID:
29484668
8.

HIV Status Disclosure in the Workplace: Positive and Stigmatizing Experiences of Health Care Workers Living with HIV.

Stutterheim SE, Brands R, Baas I, Lechner L, Kok G, Bos AER.

J Assoc Nurses AIDS Care. 2017 Nov - Dec;28(6):923-937. doi: 10.1016/j.jana.2017.06.014. Epub 2017 Jun 28.

PMID:
28751112
9.

c-Myb Regulates the T-Bet-Dependent Differentiation Program in B Cells to Coordinate Antibody Responses.

Piovesan D, Tempany J, Di Pietro A, Baas I, Yiannis C, O'Donnell K, Chen Y, Peperzak V, Belz GT, Mackay CR, Smyth GK, Groom JR, Tarlinton DM, Good-Jacobson KL.

Cell Rep. 2017 Apr 18;19(3):461-470. doi: 10.1016/j.celrep.2017.03.060.

10.

Disclosure of HIV Status to Health Care Providers in the Netherlands: A Qualitative Study.

Stutterheim SE, Sicking L, Baas I, Brands R, Roberts H, van Brakel WH, Lechner L, Kok G, Bos AE.

J Assoc Nurses AIDS Care. 2016 Jul-Aug;27(4):485-94. doi: 10.1016/j.jana.2016.02.014. Epub 2016 Feb 26.

PMID:
27005783
11.

Patient and provider perspectives on HIV and HIV-related stigma in Dutch health care settings.

Stutterheim SE, Sicking L, Brands R, Baas I, Roberts H, van Brakel WH, Lechner L, Kok G, Bos AE.

AIDS Patient Care STDS. 2014 Dec;28(12):652-65. doi: 10.1089/apc.2014.0226.

12.

[FDG-PET/CT in staging of breast carcinoma: use in tumour stage III and locoregional recurrent breast carcinoma].

Bulten BF, de Haas MJ, Rodenburg CJ, van Ooijen B, Baas IO, de Klerk JM.

Ned Tijdschr Geneeskd. 2014;158:A7035. Review. Dutch.

PMID:
24642119
13.

[Analysis of EEG characteristic at early stages of depression using method of independent components].

Grin'-Iatsenko VA, Baas I, Ponomarev VA, Kropotov IuD.

Fiziol Cheloveka. 2011 Jan-Feb;37(1):45-55. Russian.

PMID:
21469354
14.

Independent component approach to the analysis of EEG recordings at early stages of depressive disorders.

Grin-Yatsenko VA, Baas I, Ponomarev VA, Kropotov JD.

Clin Neurophysiol. 2010 Mar;121(3):281-9. doi: 10.1016/j.clinph.2009.11.015. Epub 2009 Dec 16.

PMID:
20006545
15.

EEG power spectra at early stages of depressive disorders.

Grin-Yatsenko VA, Baas I, Ponomarev VA, Kropotov JD.

J Clin Neurophysiol. 2009 Dec;26(6):401-6. doi: 10.1097/WNP.0b013e3181c298fe.

PMID:
19952564
16.

Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires rac-mediated interaction with stromal cells.

Rozenveld-Geugien M, Baas IO, van Gosliga D, Vellenga E, Schuringa JJ.

Exp Hematol. 2007 May;35(5):782-92.

PMID:
17577927
17.

Increased Rac activity is required for the progression of T-lymphomas induced by Pten-deficiency.

Strumane K, Song JY, Baas I, Collard JG.

Leuk Res. 2008 Jan;32(1):113-20. Epub 2007 May 22.

PMID:
17521720
18.

Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.

Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH.

Biol Blood Marrow Transplant. 2004 Mar;10(3):204-12.

19.

[Clinical thinking and decision making in practice. A patient with persistent fever].

Koopmans RP, Baas I, Schreuder MC, Hart W.

Ned Tijdschr Geneeskd. 2000 Jul 29;144(31):1480-4. Dutch.

PMID:
10941434
20.

Clinical applications of detecting dysfunctional p53 tumor suppressor protein.

Baas IO, Hruban RH, Offerhaus GJ.

Histol Histopathol. 1999 Jan;14(1):279-84. doi: 10.14670/HH-14.279. Review.

PMID:
9987672
21.

Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach.

Baas IO, van Rees BP, Musler A, Craanen ME, Tytgat GN, van den Berg FM, Offerhaus GJ.

J Clin Pathol. 1998 Sep;51(9):662-6.

22.

Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area.

Sturm PD, Baas IO, Clement MJ, Nakeeb A, Johan G, Offerhaus A, Hruban RH, Pitt HA.

Int J Cancer. 1998 Dec 9;78(6):695-8.

23.

p53 alterations in atypical alveolar hyperplasia of the human lung.

Slebos RJ, Baas IO, Clement MJ, Offerhaus GJ, Askin FB, Hruban RH, Westra WH.

Hum Pathol. 1998 Aug;29(8):801-8.

PMID:
9712420
24.

Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease.

Baas IO, Offerhaus GJ, Hruban RH.

Clin Microbiol Infect. 1997 Aug;3(4):393-394. No abstract available.

25.

Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.

Slebos RJ, Baas IO, Clement M, Polak M, Mulder JW, van den Berg FM, Hamilton SR, Offerhaus GJ.

Br J Cancer. 1996 Jul;74(2):165-71.

26.

K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.

Westra WH, Baas IO, Hruban RH, Askin FB, Wilson K, Offerhaus GJ, Slebos RJ.

Cancer Res. 1996 May 1;56(9):2224-8.

27.

The WAF1-mediated p53 growth-suppressor pathway is intact in the coronary arteries of heart transplant recipients.

Baas IO, Offerhaus JA, El-Deiry WS, Wu TC, Hutchins GM, Kasper EK, Baughman KL, Baumgartner WA, Chiou CJ, Hayward GS, Hruban RH.

Hum Pathol. 1996 Apr;27(4):324-9.

PMID:
8617473
28.

Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms.

Baas IO, van den Berg FM, Mulder JW, Clement MJ, Slebos RJ, Hamilton SR, Offerhaus GJ.

J Pathol. 1996 Mar;178(3):264-7.

PMID:
8778330
29.

Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma.

Mulder JW, Baas IO, Polak MM, Goodman SN, Offerhaus GJ.

Br J Cancer. 1995 Jun;71(6):1257-62.

30.

[Molecular-genetic leads for prevention and treatment of colorectal carcinoma].

Offerhaus GJ, Baas IO.

Ned Tijdschr Geneeskd. 1994 Mar 12;138(11):561-4. Review. Dutch. No abstract available.

PMID:
8139721
31.

An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms.

Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B, Hamilton SR.

J Pathol. 1994 Jan;172(1):5-12.

PMID:
7931827
32.

Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking.

Westra WH, Offerhaus GJ, Goodman SN, Slebos RJ, Polak M, Baas IO, Rodenhuis S, Hruban RH.

Am J Surg Pathol. 1993 Mar;17(3):213-20.

PMID:
8434702
33.

Supplemental Content

Support Center